Du är här
2021-07-29
Redeye: Vertiseit Q2’2021 Review - New Targets Ahead
Redeye raises its Base case for Vertiseit following its Q2 report, despite a mixed outcome. However, we believe the long-term prospects in embracing Grassfish strategy are favorable, resulting in a more SaaS-like company with a sales mix dominated by SaaS and Agency/Consultancy.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/
Attachments